Acitretin/etretinate embryopathy

Acitretin/Etretinate embryopathy is a teratogenic disorder due to acitretin or etretinate exposure during the first trimester of pregnancy, carrying a risk of fetal malformations of approximately 20%, including central nervous system, craniofacial, ear, thymic, cardiac and limb anomalies.

Also known as: fetal acitretin/etretinate syndrome, foetal acitretin/etretinate syndrome, retinoid embryopathy, Acitretine embryofetopathy, acitretin embryofetopathy, acitretin embryopathy, fetal acitretin syndrome, foetal acitretin syndrome

0 clinical trials for this condition and its sub-types.